322:
aims to develop a bridge between scientific, clinical, governmental, pharmaceutical and financial communities to advance clinical trials of sight-saving treatments and therapies. The FFB Clinical
Research Institute invests funds to support Phase I and Phase II clinical trials to expedite the commercialization of treatments for conditions such as retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal diseases, and also provides assistance to the management of clinical trials and subsequent commercialization.
126:
22:
399:
hear from prominent doctors and scientists about the latest retinal degenerative disease research, new treatments, therapies, and clinical trials. Vision
Seminars not only give affected individuals and their families critical information about research and treatments, but they also provide the hope necessary to cope with these debilitating diseases.
339:
The
Foundation has nearly 50 volunteer-led chapters across the U.S. These volunteers raise funds for research, increase public awareness, and provide support to their communities. Through its communications and public health outreach programs, the Foundation educates individuals affected with retinal
330:
The
Foundation Fighting Blindness currently funds more than 120 grants, including the modules of 14 Centers. The research projects of these grants are conducted by research investigators at more than 70 Institutions, Eye Hospitals and Universities. In addition to funding researchers within the United
352:
VisionWalk is the national signature fundraising event of the
Foundation Fighting Blindness that also acts as a celebration of the Fighting Blindness community. Occurring every fall in 36 locations, participants join teams and fund raise in the month leading up to the event. The event itself is a 5k
301:
After decades of
Foundation-funded research, several promising treatments have moved into human clinical trials, including a landmark gene therapy human study for Leber congenital amaurosis, which has enabled more than 40 children and young adults who were virtually blind to read several lines on an
213:
in 1971 by Gordon and Lulie Gund, Bernard and
Beverly Berman, and other dedicated leaders to find cures for retinal degenerations at a time when very little was known about those vision-robbing diseases. Blind from retinitis pigmentosa, Gund is Chairman of the Foundation Fighting Blindness and Chief
343:
In addition to grants and individual and corporate gifts, the
Foundation hosts a series of fundraising events across the country, including VisionWalks, Dining in the Dark dinners, and Visionary Awards galas. As promising treatments move into critical human studies, the need for research funding is
321:
The
Foundation Fighting Blindness Clinical Research Institute works to accelerate the translation of laboratory-based research into clinical trials for treatments and cures of retinal degenerative diseases. As a support organization and the translational arm of the Foundation Fighting Blindness, it
398:
The
Foundation Fighting Blindness' Vision Seminar Series provides a supportive learning environment for people living with macular degeneration, retinitis pigmentosa, and other inherited retinal degenerative diseases. Held around the country, each half-day, free seminar offers patients a forum to
389:
VISIONS is the national conference of the Foundation Fighting Blindness. It is the only event of its kind - created solely for individuals and families who are affected by retinal diseases. Nowhere else will people find such easy access to information on the latest retinal research and clinical
368:
The Foundation Fighting Blindness hosts approximately 10 annual Dining in the Dark fundraising events in various cities around the U.S. Meant to increase awareness about the challenges of the visually impaired, Dining in the Dark is an event where participants dine in the dark. This idea of
233:
Through private individual contributions, corporate philanthropy and community-based fundraising activities, the Foundation has raised more than $ 500 million since its founding and is the largest non-governmental source of research funds for inherited retinal degenerative diseases.
305:
Valproic acid, a drug that is FDA-approved to treat epilepsy, has shown promise for preserving vision in people with certain forms of retinitis pigmentosa. The Foundation has launched a human trial to test this drug and, if effective, move it quickly out to patients who need it.
309:
Foundation-funded researchers are using stem cells derived from a variety of sources, including a person's own skin, to create healthy retinal cells that can potentially restore vision. Stem cell treatments hold great promise for people with advanced vision loss.
302:
eye chart and see in dimly lit settings. This success paved the way for the development of gene therapies now in clinical trials to treat a wide range of other retinal conditions, including Stargardt disease, Usher syndrome, and age-related macular degeneration.
359:
Due to the COVID-19 virus, the FFB held the fall 2020 VisionWalk online, asking participants to take steps to support the virtual VisionWalk by using a treadmill, going on a socially distanced walk, or having a virtual meeting with teammates.
407:
Through its Partners for Retinal Health program, the Foundation works with retinal specialists throughout the country to provide the information, resources and hope patients need upon being diagnosed with a retinal degenerative disease.
353:
walk to fund raise for research sponsored by FFB, as well as to raise awareness of low vision and blind individuals. There is an emphasis on the ability and accomplishments of people impacted by lack of vision.
381:
Race to Cure Blindness is a fundraising program where participants utilize any marathon, triathlon, bike race, or other racing event as a platform to raise money for the Foundation Fighting Blindness.
356:
Since its inception in the spring of 2006, the program has raised over $ 55 million to fund sight-saving research with over 200,000 participants in the form of volunteers, team members and, sponsors.
529:
612:
313:
The Foundation is also funding clinical trials of a tiny innovative capsule that is inserted into the eye to slow vision loss from a variety of retinal degenerative diseases.
617:
39:
331:
States, Foundation funding extends internationally including laboratories in Canada, England, France, Germany, Italy, Israel, China, and the Netherlands.
298:
The Foundation funds research in a number of scientific areas including: genetics, gene therapy, nutrition, stem cells, and pharmaceutical therapies.
242:
Foundation-funded scientists at institutions throughout the world conduct research for the entire spectrum of retinal degenerative diseases including:
478:
467:
202:
and related conditions. These diseases, which affect more than 10 million Americans and millions more throughout the world, often lead to severe
186:
is to fund research that will lead to the prevention, treatment and cures for the entire spectrum of retinal degenerative diseases, including
86:
58:
390:
trials, the doctors performing the work, coping strategies, and other families from around the country living with the same diseases.
65:
105:
219:
72:
43:
259:
54:
417:
271:
275:
543:
558:
125:
32:
79:
227:
493:
456:
432:
422:
340:
disease and their families about research developments, clinical trials, and coping with low vision.
247:
243:
191:
187:
214:
Executive Officer and Chairman of Gund Investment Corporation. He is a former majority owner of the
152:
Fund research that will lead to preventions, treatments and cures for retinal degenerative diseases.
215:
516:
160:
437:
255:
199:
223:
427:
287:
279:
251:
195:
504:
606:
283:
267:
263:
530:"Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding"
370:
203:
21:
559:"Have You Ever Wondered What Dining in the Dark Was Like (And Where To Do It)?"
373:" is not unique to the foundation, as it is also practised in other locations.
505:"Gene Therapy Improves Vision in Patients with Congenital Retinal Disease."
458:
The National Alliance for Eye and Vision Research, accessed July 16, 2008
517:"Long-term Retinal Implant Study Offers Hope For Treating Blindness."
587:
15:
597:
479:
Gene Therapy Provides Vision to People who Were Nearly Blind
171:
507:, American Foundation for the Blind, accessed July 16, 2008
489:
487:
317:
Foundation Fighting Blindness Clinical Research Institute
592:
209:
The Foundation Fighting Blindness was founded as the
166:
156:
148:
140:
132:
46:. Unsourced material may be challenged and removed.
290:, and other rare retinal degenerative diseases.
593:National Neurovision Research Institute (NNRI)
8:
613:Blindness organizations in the United States
495:Retina International, accessed July 16, 2008
118:
222:) and was co-founder and part owner of the
618:Non-profit organizations based in Maryland
282:, cone-rod dystrophy, rod–cone dystrophy,
124:
117:
106:Learn how and when to remove this message
211:National Retinitis Pigmentosa Foundation
519:, Science Daily, accessed July 16, 2008
449:
7:
44:adding citations to reliable sources
544:"Fall National Virtual VisionWalk"
14:
335:Fundraising and public education
20:
481:Reuters, accessed July 16, 2008
220:National Basketball Association
55:"Foundation Fighting Blindness"
31:needs additional citations for
469:Forbes, accessed July 16, 2008
1:
588:Foundation Fighting Blindness
184:Foundation Fighting Blindness
119:Foundation Fighting Blindness
294:Research and clinical trials
403:Partners for Retinal Health
634:
418:Leber congenital amaurosis
344:greater than ever before.
272:Leber congenital amaurosis
123:
230:). Berman died in 1996.
206:or complete blindness.
377:Race to Cure Blindness
228:National Hockey League
394:Vision Seminar Series
276:Bardet–Biedl syndrome
433:Retinitis pigmentosa
423:Macular degeneration
248:macular degeneration
244:retinitis pigmentosa
192:macular degeneration
188:retinitis pigmentosa
40:improve this article
216:Cleveland Cavaliers
182:The mission of the
120:
565:. Inside-Out Media
385:VISIONS conference
364:Dining in the Dark
161:Columbia, Maryland
532:. 9 January 2020.
438:Stargardt disease
256:Stargardt disease
200:Stargardt disease
180:
179:
116:
115:
108:
90:
625:
575:
574:
572:
570:
557:Ferguson, Jill.
554:
548:
547:
540:
534:
533:
526:
520:
514:
508:
502:
496:
491:
482:
476:
470:
465:
459:
454:
238:Diseases studied
176:
173:
128:
121:
111:
104:
100:
97:
91:
89:
48:
24:
16:
633:
632:
628:
627:
626:
624:
623:
622:
603:
602:
584:
579:
578:
568:
566:
556:
555:
551:
542:
541:
537:
528:
527:
523:
515:
511:
503:
499:
492:
485:
477:
473:
466:
462:
455:
451:
446:
414:
405:
396:
387:
379:
366:
350:
337:
328:
319:
296:
240:
224:San Jose Sharks
170:
112:
101:
95:
92:
49:
47:
37:
25:
12:
11:
5:
631:
629:
621:
620:
615:
605:
604:
601:
600:
595:
590:
583:
582:External links
580:
577:
576:
549:
535:
521:
509:
497:
483:
471:
460:
448:
447:
445:
442:
441:
440:
435:
430:
428:Usher syndrome
425:
420:
413:
410:
404:
401:
395:
392:
386:
383:
378:
375:
365:
362:
349:
346:
336:
333:
327:
324:
318:
315:
295:
292:
288:Refsum disease
280:cone dystrophy
252:Usher syndrome
239:
236:
196:Usher syndrome
178:
177:
172:fightblindness
168:
164:
163:
158:
154:
153:
150:
146:
145:
142:
138:
137:
134:
130:
129:
114:
113:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
630:
619:
616:
614:
611:
610:
608:
599:
596:
594:
591:
589:
586:
585:
581:
564:
560:
553:
550:
545:
539:
536:
531:
525:
522:
518:
513:
510:
506:
501:
498:
494:
490:
488:
484:
480:
475:
472:
468:
464:
461:
457:
453:
450:
443:
439:
436:
434:
431:
429:
426:
424:
421:
419:
416:
415:
411:
409:
402:
400:
393:
391:
384:
382:
376:
374:
372:
363:
361:
357:
354:
347:
345:
341:
334:
332:
325:
323:
316:
314:
311:
307:
303:
299:
293:
291:
289:
285:
284:achromatopsia
281:
277:
273:
269:
268:retinoschisis
265:
264:choroideremia
261:
257:
253:
249:
245:
237:
235:
231:
229:
225:
221:
217:
212:
207:
205:
201:
197:
193:
189:
185:
175:
169:
165:
162:
159:
155:
151:
147:
143:
139:
135:
131:
127:
122:
110:
107:
99:
96:November 2012
88:
85:
81:
78:
74:
71:
67:
64:
60:
57: –
56:
52:
51:Find sources:
45:
41:
35:
34:
29:This article
27:
23:
18:
17:
569:15 September
567:. Retrieved
563:iExplore.com
562:
552:
538:
524:
512:
500:
474:
463:
452:
406:
397:
388:
380:
367:
358:
355:
351:
342:
338:
329:
320:
312:
308:
304:
300:
297:
260:Best disease
241:
232:
210:
208:
183:
181:
157:Headquarters
102:
93:
83:
76:
69:
62:
50:
38:Please help
33:verification
30:
371:dark dining
204:vision loss
607:Categories
598:VisionWalk
444:References
348:VisionWalk
144:Non-Profit
66:newspapers
133:Formation
412:See also
167:Website
149:Purpose
80:scholar
326:Grants
82:
75:
68:
61:
53:
87:JSTOR
73:books
571:2016
174:.org
141:Type
136:1971
59:news
42:by
609::
561:.
486:^
286:,
278:,
274:,
270:,
266:,
262:,
258:,
254:,
250:,
246:,
198:,
194:,
190:,
573:.
546:.
369:"
226:(
218:(
109:)
103:(
98:)
94:(
84:·
77:·
70:·
63:·
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
